We’re thrilled to share another remarkable milestone in our journey of scientific collaboration.
Our latest article,” “Characterization of Enzyme-Linked Immunosorbent Assay (ELISA) for Quantification of Antibodies against Salmonella Typhimurium and Salmonella Enteritidis O-Antigens in Human Sera.” written in partnership with GVGH on behalf of the Vacc-iNTS Consortium Collaborators, is now available for you to explore!
Nontyphoidal Salmonella (NTS) poses a significant global health challenge, affecting both children and adults. With no vaccines available, understanding disease incidence and vaccine effectiveness is crucial. This article presents a cutting-edge ELISA assay, meticulously characterized for accuracy, sensitivity, and specificity.
Read the full article here: https://bit.ly/3QFY4O6
At VisMederi Group, we’re dedicated to pioneering solutions for global health challenges. Stay tuned for more updates on our journey towards a healthier future!
